- Patients typically need to allow 1-3 hours for their study visits. During these visits, the patients will be requested to fill out study questionnaires, have their vital signs taken, labs drawn, physical exam/assessments by a physician, and receive study medication.
- Subjects may decline participation and/or withdraw consent and at any time. A study termination visit will still be necessary, even though study drug will no longer be administered.
Trial Completion Visit:
- During their final scheduled visit, the subject completes their participation in the study. This is usually an abbreviated visit to follow up on adverse events; it typically occurs a month after the final dosage of medication; however, all studies have individual requirements and timelines.